Skip to main content
. Author manuscript; available in PMC: 2009 Aug 15.
Published in final edited form as: J Neurol Sci. 2008 May 2;271(1-2):61–67. doi: 10.1016/j.jns.2008.03.012

Figure 3.

Figure 3

Systolic blood pressure (SBP) declines and 3-month adverse outcomes. A) Rankin score > 3 and B) death. Odds ratios (OR) with 95% confidence intervals (CI) >1 indicate a significantly increased likelihood of poor outcome or death. *Treatment by SBP decline interactions were detected at the 0.10 level.